Dr Michael Cilento
School of Medicine
College of Health
Dr Michael Cilento MBBS FRACP is a medical oncologist and PhD candidate in the Prostate Cancer Research Group at the South Australian Health and Medical Research Institute (SAHMRI). Dr Cilento received his medical degree from the University of Adelaide and did his residency at the Royal Adelaide Hospital. He completed his oncology training in South Australia, which was followed by a fellowship in early drug development and phase 1 clinical trials at the Peter MacCallum Cancer Centre Melbourne. Dr Cilento later joined the Royal Adelaide Hospital as a consultant medical oncologist in 2025, where he provides care to people affected by genitourinary, breast, gynaecological, and lower gastrointestinal cancers.
Dr Cilento's clinical and research interests focus on genitourinary cancers; his PhD research is utilising novel spatial profiling methods to identify drivers of potentially lethal prostate cancer.
| Year | Citation |
|---|---|
| 2023 | Cilento, M. A., Mah, C. Y., Martelotto, L., Sweeney, C. J., & Butler, L. M. (2023). Multiomic analysis workflow for biomarker discovery in human prostate cancer. Poster session presented at the meeting of ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. WILEY. |
| 2022 | Cilento, M. A., Chalwin, R., Hocking, C., Chan, L., Smithers, L., & Joshi, R. (2022). Morbidity and mortality of oncology patients admitted to an intensive care unit. Poster session presented at the meeting of Abstracts from the RACP Congress 2022 A Climate for Change as published in Internal Medicine Journal. Australia: John Wiley & Sons. DOI |
| 2021 | Cilento, M., & Roberts-Thomson, R. (2021). Weight changes during adjuvant nivolumab for resected melanoma. Poster session presented at the meeting of Poster Abstracts. Asia-Pacific Journal of Clinical Oncology, 17: 110-208.. Virtual. DOI |